Current and historical daily PE Ratio for Intra-Cellular Therapies Inc (
BSP:I2TC34
) from 2023 to Jun 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Intra-Cellular Therapies stock (BSP:I2TC34) PE ratio as of Jun 22 2024 is 0.
More Details
Intra-Cellular Therapies Inc (BSP:I2TC34) PE Ratio (TTM) Chart
Intra-Cellular Therapies Inc (BSP:I2TC34) PE Ratio (TTM) Historical Data
View and export this data going back to 2023. Start your Free Trial
Total 238
- 1
- 2
- 3
Intra-Cellular Therapies PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-22 | At Loss | 2024-04-22 | At Loss |
2024-06-21 | At Loss | 2024-04-19 | At Loss |
2024-06-20 | At Loss | 2024-04-18 | At Loss |
2024-06-19 | At Loss | 2024-04-17 | At Loss |
2024-06-18 | At Loss | 2024-04-16 | At Loss |
2024-06-17 | At Loss | 2024-04-15 | At Loss |
2024-06-14 | At Loss | 2024-04-12 | At Loss |
2024-06-13 | At Loss | 2024-04-11 | At Loss |
2024-06-12 | At Loss | 2024-04-10 | At Loss |
2024-06-11 | At Loss | 2024-04-09 | At Loss |
2024-06-10 | At Loss | 2024-04-08 | At Loss |
2024-06-07 | At Loss | 2024-04-05 | At Loss |
2024-06-06 | At Loss | 2024-04-04 | At Loss |
2024-06-05 | At Loss | 2024-04-03 | At Loss |
2024-06-04 | At Loss | 2024-04-02 | At Loss |
2024-06-03 | At Loss | 2024-04-01 | At Loss |
2024-05-31 | At Loss | 2024-03-29 | At Loss |
2024-05-30 | At Loss | 2024-03-28 | At Loss |
2024-05-29 | At Loss | 2024-03-27 | At Loss |
2024-05-28 | At Loss | 2024-03-26 | At Loss |
2024-05-27 | At Loss | 2024-03-25 | At Loss |
2024-05-24 | At Loss | 2024-03-22 | At Loss |
2024-05-23 | At Loss | 2024-03-21 | At Loss |
2024-05-22 | At Loss | 2024-03-20 | At Loss |
2024-05-21 | At Loss | 2024-03-19 | At Loss |
2024-05-20 | At Loss | 2024-03-18 | At Loss |
2024-05-17 | At Loss | 2024-03-15 | At Loss |
2024-05-16 | At Loss | 2024-03-14 | At Loss |
2024-05-15 | At Loss | 2024-03-13 | At Loss |
2024-05-14 | At Loss | 2024-03-12 | At Loss |
2024-05-13 | At Loss | 2024-03-11 | At Loss |
2024-05-10 | At Loss | 2024-03-08 | At Loss |
2024-05-09 | At Loss | 2024-03-07 | At Loss |
2024-05-08 | At Loss | 2024-03-06 | At Loss |
2024-05-07 | At Loss | 2024-03-05 | At Loss |
2024-05-06 | At Loss | 2024-03-04 | At Loss |
2024-05-03 | At Loss | 2024-03-01 | At Loss |
2024-05-02 | At Loss | 2024-02-29 | At Loss |
2024-05-01 | At Loss | 2024-02-28 | At Loss |
2024-04-30 | At Loss | 2024-02-27 | At Loss |
2024-04-29 | At Loss | 2024-02-26 | At Loss |
2024-04-26 | At Loss | 2024-02-23 | At Loss |
2024-04-25 | At Loss | 2024-02-22 | At Loss |
2024-04-24 | At Loss | 2024-02-21 | At Loss |
2024-04-23 | At Loss | 2024-02-20 | At Loss |
Intra-Cellular Therapies Inc (BSP:I2TC34) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Intra-Cellular Therapies Inc
NAICS : 325412
SIC : 2834
ISIN : BRI2TCBDR009
Description